Alcohol and drug misuse / Iosief Abraha, Cristina Cusi.
By: Abraha, Iosief.
Contributor(s): Cusi, Cristina | Cochrane Collaboration.Material type: BookSeries: Cochrane book series: Publisher: Chichester, West Sussex : John Wiley & Sons, 2013Description: 1 online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9781118454473; 1118454472; 9781118454480; 1118454480; 9781118454497; 1118454499; 9781118454503; 1118454502.Subject(s): Drug abuse -- Treatment | Alcoholism -- Treatment | Substance-Related Disorders -- therapy | Comparative Effectiveness Research | Early Medical Intervention | Social Support | SELF-HELP -- Substance Abuse & Addictions -- Drug Dependence | SELF-HELP -- Substance Abuse & Addictions -- General | SELF-HELP -- Twelve-Step Programs | Alcoholism -- Treatment | Drug abuse -- TreatmentGenre/Form: Review. | Electronic books.Additional physical formats: Print version:: Alcohol and drug misuse.DDC classification: 616.86/06 Online resources: Wiley Online Library
Includes bibliographical references and index.
Print version record and CIP data provided by publisher.
Part 1. Alcohol. Psychosocial interventions -- Effectiveness of brief alcohol interventions in primary care populations -- Brief interventions for heavy alcohol users admitted to general hospital wards -- Alcoholics Anonymous and other 12-step programmes for alcohol dependence -- Mentoring adolescents to prevent substance use disorders -- Universal school-based prevention programmes for alcohol misuse in young people -- Universal multicomponent prevention programmes for alcohol misuse in young people -- Universal family-based prevention programmes for alcohol misuse in young people -- Social norms interventions to reduce alcohol misuse in university or college students -- Psychosocial interventions for women enrolled in alcohol treatment during pregnancy -- Pharmacological interventions -- Benzodiazepines for alcohol withdrawal -- Anticonvulsants for alcohol withdrawal -- Acamprosate for alcohol dependence -- Baclofen for alcohol withdrawal -- Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse -- Psychotropic analgesic nitrous oxide for alcohol withdrawal -- Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal -- Opioid antagonists for alcohol dependence -- Pharmacologic interventions for pregnant women enrolled in alcohol treatment.
Part 2. Drugs. Psychosocial interventions -- School-based prevention for illicit substance use disorders -- Interventions for prevention of substance use disorders by young people delivered in non-school settings -- Case management for persons with substance use disorders -- Motivational interviewing for substance use disorders -- Therapeutic communities for substance use disorders -- Interventions for drug-using offenders in the courts, secure estabishments and the community -- Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions -- Cocaine dependence -- Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders -- Antidepressants for cocaine dependence -- Antipsychotic medications for cocaine dependence -- Anticonvulsants for cocaine dependence -- Dopamine agonists for cocaine dependence -- Disulfiram for the treatment of cocaine dependence -- Efficacy of psychostimulant drugs for cocaine dependence -- Auricular acupuncture for cocaine dependence -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence -- Methadone at tapered doses for the management of opioid withdrawal -- Methadone maintenance at different dosages for opioid dependence -- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence -- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal -- Opioid antagonists with minimal sedation for opioid withdrawal -- Oral naltrexone maintenance treatment for opioid dependence -- Sustained-release naltrexone for opioid dependence -- Heroin maintenance for chronic heroin-dependent individuals -- LAAM maintainance verus methadone maintenance for heroin dependence -- Detoxification treatments for opiate-dependent adolescents -- Maintenance treatments for opiate-dependent adolescents -- Maintenance agonist treatment for opiate-dependent adolescents -- Maintenance agonist treatments for opiate-dependent pregnant women -- Pharmacological treatments for depression during opoid dependence -- Inpatient versus other setttings for detoxification for opiod dependence -- Psychotherapeutic interventions for cannabis use or dependence in outpatient settings -- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings -- Treatment for amphetamine dependence -- Treatment for amphetamine withdrawal -- Treatment for amphetamine psychosis -- Treatment for methaqualone dependence in adults.